Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg

7680684700033 CH-68470 Kapseln

No image available

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2026
Patient information leaflet
Français
01/05/2026
Patient information leaflet
Italien
01/05/2026
Summary of Product Characteristics
Allemand
01/05/2026
Summary of Product Characteristics
Français
01/05/2026
Summary of Product Characteristics
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
budesonidum
3.0 MG Substance Wirkstoff (Principe actif)
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
maydis amylum
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:1
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:2
- Substance HNIDK
ammonio methacrylatis copolymerum B
- Substance HNIDK
ammonio methacrylatis copolymerum A
- Substance HNIDK
triethylis citras
- Substance HNIDK
talcum
- Substance HNIDK
E 133
- Substance FIMDK
E 104
- Substance FIMDK
E 127
- Substance FIMDK
E 171
- Substance FNIDK
gelatina
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.005 MG Substance HBESI
copolymerum macrogolo et alcoholi poly(vinylico) constatum
- Substance HNIDK
talcum
- Substance HNIDK
glyceroli monocaprylocapras
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK

Reimbursement information

Public price
CHF 96.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2026

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68470
Drug name
Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung
Galenic form
KAHAM
ATC Code
A07EA06
Authorization status
Z
Dispensing category
B
First authorization
08/07/2022
Authorization expiration date
07/07/2027
IT Number
04.99.0.
Domain
Human medicine
Field of application
Morbus Crohn, Kollagene Colitis

Package details

Description (FR)
BUDESONID MEPHA caps ret 3 mg 100 pce bte
Description (DE)
BUDESONID MEPHA Ret Kaps 3 mg 100 Stk Ds
Market launch
15/05/2026
Narcotic (BTM)
No

Original drug

Budenofalk 2 mg, Rektalschaum
GTIN: 7680592630019
CHF 102.55
View original

Other package sizes (2)

BUDESONID MEPHA caps ret 3 mg 50 pce
50 KAP
GTIN: 7680684700019
View
BUDESONID MEPHA caps ret 3 mg 100 pce
100 KAP
GTIN: 7680684700026
View
Buy us a coffee Explore the data